---

$9.90

-0.1900 ( -1.88% ) 525.7K

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-03-26	Sale	-16851.00	Curran Terrie
2024-01-25	Sale	-3703703.00	TAKEDA PHARMACEUTICAL CO LTD
2024-01-22	Sale	-475000.00	Curran Terrie
2024-01-22	Sale	-130000.00	Nabulsi Azmi
2024-01-22	Sale	-6307.00	Henderson Molly
2023-11-21	Sale	-2127.00	Henderson Molly
2023-11-08	Buy	1000.00	Parikh Asit
2023-11-03	Sale	-22500.00	Henderson Molly
2023-11-03	Sale	-32500.00	Nabulsi Azmi
2023-11-03	Sale	-37500.00	Curran Terrie